DrugPatentWatch Database Preview

Aripiprazole lauroxil - Generic Drug Details

« Back to Dashboard

What are the generic drug sources for aripiprazole lauroxil and what is the scope of aripiprazole lauroxil freedom to operate?

Aripiprazole lauroxil is the generic ingredient in two branded drugs marketed by Alkermes Inc and is included in two NDAs. There are eight patents protecting this compound. Additional information is available in the individual branded drug profile pages.

Aripiprazole lauroxil has eighty-seven patent family members in twenty-six countries.

There are forty-nine drug master file entries for aripiprazole lauroxil. One supplier is listed for this compound.

Summary for aripiprazole lauroxil

International Patents:	87
US Patents:	8
Tradenames:	2
Applicants:	1
NDAs:	2
Drug Master File Entries:	49
Suppliers / Packagers:	1
Bulk Api Vendors:	12
Clinical Trials:	5
Patent Applications:	32
DailyMed Link:	aripiprazole lauroxil at DailyMed

Synonyms for aripiprazole lauroxil

(7-(4-(4-(2,3-Dichlorophenyl)piperazin-1-yl)butoxy)-2-oxo-3,4-dihydroquinolin-1(2H)-yl)methyl dodecanoate

[7-[4-[4-(2,3-dichlorophenyl)piperazin-1-yl]butoxy]-2-oxo-3,4-dihydroquinolin-1-yl]methyl dodecanoate

[7-{4-[4-(2,3-dichlorophenyl)piperazin-1-yl]butoxy}-2-oxo-3,4-dihydroquinolin-1(2H)-yl]methyl dodecanoate

1259305-29-7

AKOS030627657

ALKS 9070

ALKS 9072

Aripiprazol- Lauroxil

Aripiprazole lauroxil (USAN)

Aripiprazole lauroxil [USAN]

Aristada

Aristada (TN)

B786J7A343

CHEBI:90930

CHEMBL2219425

D10364

Dodecanoic acid [7-[4-[4-(2,3-dichlorophenyl)-1-piperazinyl]butoxy]-3,4-dihydro-2-oxo-1(2H)-quinolinyl]methyl ester

Dodecanoic acid, (7-(4-(4-(2,3-dichlorophenyl)-1-piperazinyl)butoxy)-3,4-dihydro-2-oxo-1(2H)-quinolinyl)methyl ester

DTXSID60154997

MFCD26967976

RDC 3317

RDC-3317

SCHEMBL1044330

UNII-B786J7A343

ZINC95564895

US Patents and Regulatory Information for aripiprazole lauroxil

Applicant	Tradename	Generic Name	Dosage	NDA	Approval Date	TE	Type	RLD	RS	Patent No.	Patent Expiration	Product	Substance	Delist Req.	Exclusivity Expiration
Alkermes Inc	ARISTADA	aripiprazole lauroxil	SUSPENSION, EXTENDED RELEASE;INTRAMUSCULAR	207533-004	Jun 5, 2017		RX	Yes	No
Alkermes Inc	ARISTADA	aripiprazole lauroxil	SUSPENSION, EXTENDED RELEASE;INTRAMUSCULAR	207533-003	Oct 5, 2015		RX	Yes	Yes				Y
Alkermes Inc	ARISTADA	aripiprazole lauroxil	SUSPENSION, EXTENDED RELEASE;INTRAMUSCULAR	207533-003	Oct 5, 2015		RX	Yes	Yes

International Patents for aripiprazole lauroxil

Country	Document Number	Estimated Expiration
Hungary	E032109
European Patent Office	2897592
Mexico	2013010471

Supplementary Protection Certificates for aripiprazole lauroxil

Supplementary Protection Certificate	SPC Country	SPC Expiration	SPC Description
00669	Netherlands		PRODUCT NAME: ARIPIPRAZOLE; REGISTRATION NO/DATE: EU/1/13/882 20131115
427	Luxembourg		PRODUCT NAME: ARIPIPRAZOLE
C/GB04/039	United Kingdom		PRODUCT NAME: ARIPIPRAZOLE OR A SALT THEREOF; REGISTERED: UK EU/1/04/276/001 20040604; UK EU/1/04/276/002 20040604; UK EU/1/04/276/003 20040604; UK EU/1/04/276/004 20040604; UK EU/1/04/276/005 20040604; UK EU/1/04/276/006 20040604; UK EU/1/04/276/007 20040604; UK EU/1/04/276/008 20040604; UK EU/1/04/276/009 20040604; UK EU/1/04/276/010 20040604; UK EU/1/04/276/011 20040604; UK EU/1/04/276/012 20040604; UK EU/1/04/276/013 20040604; UK EU/1/04/276/014 20040604; UK EU/1/04/276/015 20040604; UK EU/1/04/276/016 20040604; UK EU/1/04/276/017 20040604; UK EU/1/04/276/018 20040604; UK EU/1/04/276/019 20040604; UK EU/1/04/276/020 20040604